Sweden· SE-20130626000147
Fortum 250 mg Pulver till injektionsvätska, lösning
A medicinal product containing ceftazidime, registered in Sweden by Sandoz A/S.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ceftazidime
- Manufacturer
- Sandoz A/S
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20130626000147
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftazidime in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCeftazidim SandozSandoz GmbH
- United KingdomFortum 250mg powder for solution for injection vialsGlaxoSmithKline UK Ltd
- CzechiaALTECIMMedochemie Ltd., Limassol
- SpainALFAGEM 1 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIONMedochemie Limited
- BelgiumCeftazidim Fresenius Kabi 1000 mgFresenius Kabi
- FranceCEFTAZIDIME ARROW 1 g, poudre pour solution injectable (IM,IV)EUGIA PHARMA (MALTA) (MALTE)
- GermanyCeftazidim Dali PharmaMylan Germany Gmbh
- United StatesCeftazidimeSagent Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
- Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Bulgaria · Алфагем, Зидимцеф
- Cyprus · Alfagem, Cezid
- Czechia · Altecim, Ceftazidim Aptapharma
- Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
- Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Estonia · Altecim, Ceftazidime Fresenius Kabi
- Spain · Alfagem, Ceftazidima Kabi
- Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
- United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
- Greece · Alfagem, Ceftaridem
- Croatia · Altecim, Cefaz
- Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
- Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
- Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
- Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
- Lithuania · Biotum, Ceftazidime Kabi
- Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
- Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
- Malta · Alfagem, Ceftazidima Fresenius
- Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
- Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
- Poland · Biotum, Ceftazidim Aptapharma
- Portugal · Alfagem, Ceftazidima Accord
- Romania · Alfagem, Ceftamil
- Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
- Slovakia · Ceftazidim Ash, Ceftazidim Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/494a81b8-c1cd-4422-bdfb-55fadf55f485 GET /v1/drugs/494a81b8-c1cd-4422-bdfb-55fadf55f485?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20130626000147",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20130626000147",
"product_doc_link": "https://docetp.mpa.se/LMF/Fortum%20powder%20for%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee807a4115.pdf"
}See everything about ceftazidime.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.